论文部分内容阅读
目的:探讨布地奈德与可必特联合雾化吸入治疗重症哮喘的疗效。方法:将2011年4月至2013年1月本院收治的134例重症哮喘患者随机分为治疗组和对照组,每组各67例。治疗组给予布地奈德混悬液2 mL、可必特2.5 mL喷射雾化吸入;对照组采用氨茶碱常规治疗。结果:治疗组和对照组有效率分别为88%和63%,治疗组有效率明显高于对照组(χ2=11.619,P<0.01)。两组治疗后6 h FVC、FEV1、PaCO2、PaO2与刚入选时比较,差异均有统计学意义(P<0.01)。治疗后2、6 h,两组FVC、FEV1、PaCO2、PaO比较,差异均有统计学意义(P<0.01)。结论:可必特与布地奈德联合雾化吸入治疗支气管哮喘急性发作疗效明显。
Objective: To investigate the curative effect of budesonide and beide special combined inhalation on severe asthma. Methods: A total of 134 severe asthma patients admitted to our hospital from April 2011 to January 2013 were randomly divided into treatment group and control group, with 67 cases in each group. The treatment group was given budesonide suspension 2 mL, may be special 2.5 mL spray atomization inhalation; control group aminophylline conventional treatment. Results: The effective rates of the treatment group and the control group were 88% and 63% respectively, and the effective rate of the treatment group was significantly higher than that of the control group (χ2 = 11.619, P <0.01). The differences of FVC, FEV1, PaCO2 and PaO2 between the two groups 6 h after treatment were statistically significant (P <0.01). At 2 and 6 h after treatment, the differences of FVC, FEV1, PaCO2 and PaO between the two groups were statistically significant (P <0.01). Conclusion: It is effective to treat bronchial asthma with benezole combined with budesonide inhalation for acute attack of bronchial asthma.